Dysfunctions in nonthoracotomy cardioverter/defibrillator lead systems: Clinical importance of device implemented diagnostic and measurement functions;Dysfunktionen transvenoser kardioverter/defibrillator- elektrodensysteme: Klinische bedeutung systemintegrierter diagnose- und messfunktionen - Moglichkeiten einer teilautomatisierten systemkontrolle

Zeitschrift fur Kardiologie

Volumn 87, Issue 8, 1998, Pages 630-639

  Schulte, B ^a   Schwarz, T ^a   Sperzel, J ^a   Pitschner, H F ^a   Klovekorn W P ^a   Neuzner, J ^a  

^a KERCKHOFF HEART CENTER   (Germany)

Author keywords

Automated system controll with patient alert; Device implemented diagnostic and measurement features; Lead failures; Nonthoracotomy cardioverter defibrillator systems

Indexed keywords

ADULT; AGED; ARTICLE; AUTOMATION; CARDIOVERSION; CONTROL SYSTEM; DEFIBRILLATOR; DEVICE; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; THORACOTOMY; ELECTRODE; EQUIPMENT; FOLLOW UP; INSTRUMENTATION; MIDDLE AGED; RETROSPECTIVE STUDY; SIGNAL PROCESSING; SYSTEM ANALYSIS;

ADULT; AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; ELECTRODES; EQUIPMENT FAILURE ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SIGNAL PROCESSING, COMPUTER-ASSISTED; SYSTEMS ANALYSIS;

EID: 0032140670     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050222     Document Type: Article

References (26)

1. Andresen D, Block M, Borggrefe M, Brachmann J, Goedel-Meinen L, Gonska BD, Hohnloser S, Kuck KH, Kunze KP, Trappe J, Treese N, Volkmann HJ (1994) Empfehlungen zur Implantation von Defibrillatoren. Z Kardiol 183:242-245
2. ACC/AHA Task Force Report (1991) Guidelines for implantation of cardiac pacemakers and antitachyarrhythmia devices. Circulation 84:455-467
3. A Task Force of the Working Groups on Cardiac Arrhythmias and Cardiac Pacing of the European Society of Cardiology (1992) Guidelines for the use of implantable cardioverter-defibrillators. Eur Heart J 13:1304-1310
4. Fahry GJ, Kleman JM, Wilkoff BL, Morant VA, Pinsky SL (1995) Low incidence of lead related complications associated with nonthoracotomy implantable cardioverter defibrillator systems. Pace 18:1722-1728
5. Fischer W, Ritter P (eds) (1997) Praxis der Herzschrittmachertherapie. Springer Verlag, Berlin Heidelberg New York
6. Gallik DM, Ben-Zur UN, Gross JN, Furman S (1996) Lead fracture in cephalic versus subclavian approach with transvenous implantable cardioverter defibrillator systems. Pace 19:1089-1094
7. Haddad L, Padula LE, Moreau M, Schoenfeld MH (1994) Troubleshooting implantable cardioverter defibrillator system malfunctions: The role of impedance measurement. Pace 17:1456-1461
8. KAPPA DR 401/403, Gebrauchsanweisung, Medtronic, Minneapolis MN, USA, Juli 1997
9. Korte T, Jung W, Spehl S, Wolpert C, Moosdorf R, Manz M, Lüderitz B (1995) Incidence of ICD lead related complications during long-term follow-up; comparison of epicardial and endocardial electrode systems. Pace 18:2053-2061
10. Lawton JS, Ellenbogen KA, Wood MA, Stambler BS, Herre JM, Nath S, Bernstein RC, DiMarco JP, Haines DE, Szentpetery S, Baker LD, Damiano RJ (1996) Sensing lead-related complications in patients with transvenous implantable cardioverter-defibrillators. Am J Cardiol 78:647-651
11. Lehmann MH, Saksena S (1991) Implantable cardioverter-defibrillators in cardiovascular practice: report of the Policy Conference of the North American Society of Pacing and Electrophysiology. NASPE Policy Conference Committee. Pace 14:969-979
12. Mattke S, Müller D, Markewitz A, Kaulbach H, Schmöckel M, Dorwarth U, Hoffmann E, Steinbeck G (1995) Failures of epicardial and transvenous leads for implantable cardioverter defibrillators. Am Heart J 130:1040-1044
13. Mewis C, Kühlkamp V, Dörnberger V, Mermi J, Seipel L (1997) Hohe Inzidenz von Isolatorbrüchen bei transvenös implantierten Kardioverter-Defibrillatoren. Z Kardiol 86:85-94
14. Mortensen PT, Nielsen JC, Hansen PS, Pedersen AK (1988) High risk of CPI, Endotak sensing lead fracture: possible association to the implantation procedure. Pace 21:827(abstract)
15. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M (1996) Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med 335:1123-1130
16. Neuzner J, Pitschner HF, König S, Stöhring R, Schlepper M (1995) Stored electrograms in cardioverter/defibrillator therapy: accuracy of rhythm diagnosis in 335 spontaneous arrhythmia episodes. J Ambulatory Monitoring 8:1-9
17. Neuzner J, Dürsch M, Sperzel J, König S, Schlepper M, Pitschner HF (1997) Funktionsstörungen durch die Detektion von Myopotentialen: Ursache inadäquater Therapieabgaben bei implantierbaren Kardioverter/Defibrillatoren. Z Kardiol 86:241
18. Newman D, Dorian P, Downar E, Harris K, Cameron D, Waxman M, Hamilton R, Gow R, Hardy J (1992) Use of telemetry functions in the assessment of implanted device activity. Am J Cardiol 70:616-621
19. Roelke M, O'Nunain SS, Osswald S, Garan H, Harthorne JW, Ruskin JN (1995) Subclavian crush syndrome complicating transvenous cardioverter defibrillator systems. Pace 18:973-979
20. Schwartzman D, Nallamothu N, Callans DJ, Preminger MW, Gottlieb CD, Marchlinski FE (1995) Postoperative lead-related complications in patients with nonthoracotomy defibrillation lead systems. J Am Coll Cardiol 226:776-786
21. Schwartzman D, Hull M, Callans D, Gottlieb CD, Marchlinski FE (1996) Serial defibrillation lead impedance in patients with epicardial and nonthoracotomy lead systems. J Cardiovasc Electrophysiol 7:697-703
22. Stambler BS, Wood MM, Damiano RJ, Greenway PS, Smutka ML, Ellenbogen KA (1994) Sensing/pacing lead complications with a newer generation implantable cardioverter-defibrillator: Worldwide experience from the guardian ATP 42210 clinical trial. J Am Coll Cardiol 23:123-132
23. VENTAK PRxII 1715/VENTAK PRxIII 1710/1725, Gebrauchsanweisung. Cardiac Pacemakers, St. Paul, MN, USA, 1994
24. VENTAK MINI 1740-1745, Gebrauchsanweisung. Cardiac Pacemakers, St. Paul, MN, USA, 1995
25. Weber M, Block M, Brunn J, Bänsch D, Böcker D, Hammel D, Gietzen F, Breithardt G (1996) Inadäquate Therapien durch implantierbare Kardioverter-Defibrillatoren: Inzidenz, Ursachen, prädiktive Faktoren und Vermeidungsstrategien. Z Kardiol 85:809-819
26. Wever EFD, Hauer RNW, Schrijvers G, Van-Capelle FJL, Tijssen JGP, Crijns HJGM, Algra A, Ramanna H, Bakker PFA, Robles-de-Medina EO (1996) Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors: A randomized study. Circulation 93:489-496